DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
motexafin gadolinium is an investigational drug.
There have been 36 clinical trials for motexafin gadolinium. The most recent clinical trial was a Phase 3 trial.
The most common disease conditions in clinical trials are Lung Neoplasms, Lymphoma, and Nervous System Neoplasms. The leading clinical trial sponsors are Pharmacyclics LLC., National Cancer Institute (NCI), and Northwestern University.
Recent Clinical Trials for motexafin gadolinium
|Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma||Spectrum Pharmaceuticals, Inc||Phase 2|
|Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy||National Cancer Institute (NCI)||N/A|
|Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy||American College of Radiology Imaging Network||N/A|